113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03936894 (ClinicalTrials.gov)	May 1, 2019	29/4/2019	Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy	A Single Escalating Dose Pilot Trial of Canakinumab(ILARIS®) Assessing Safety and Biomarker Changes ...	Duchenne Muscular Dystrophy	Drug: Canakinumab Injection [Ilaris]	Children's National Research Institute	Foundation to Eradicate Duchenne	Recruiting	2 Years	N/A	Male	6	Phase 1/Phase 2	United States

First Previous1Next Last